Prabhakar Tipirneni, MD
Otolaryngology · Wakefield, RINPI 1124059555
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,088 of the $3,277 with a category attached, or 63.7%. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 41.7% of the total. Reporting peaked in 2019 at $1,615 and has fallen 90.1% since, to $161 in 2025.
Across 71 payments — averaging $46.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Intersect ENT, Inc.$769
- GSK$482
- Regeneron Healthcare Solutions, Inc.$182
- Acclarent, Inc$153
- Sanofi$126
- plus $197 from 7 others
What the payments were for
- Travel & lodging$2,08864%
- Food & beverage$1,18936%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $1,367 |
| Intersect ENT, Inc. | 3 | $769 |
| GSK | 41 | $482 |
| Regeneron Healthcare Solutions, Inc. | 6 | $182 |
| Acclarent, Inc | 3 | $153 |
| Sanofi | 6 | $126 |
| AstraZeneca | 4 | $66 |
| Stryker | 2 | $38 |
| Optinose US, Inc. | 1 | $22 |
| Aerin Medical Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Merck | 1 | $18 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,277 in reported general payments places this provider in the 60th percentile of 23 otolaryngology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 134 | $5,022 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 36 | $2,953 |
| Esomeprazole Magnesium | 83 | $1,766 |
| CefuroximeCefuroxime Axetil | 76 | $1,491 |
| Mupirocin | 175 | $1,343 |
| Fluticasone Propionate | 49 | $1,302 |
| Methylprednisolone | 95 | $684 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 13 | $675 |
| Ofloxacin | 12 | $469 |
| Pantoprazole Sodium | 57 | $422 |
| Omeprazole | 35 | $377 |
| Meclizine Hcl | 33 | $329 |
| Famotidine | 16 | $311 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 36 | $243 |
| Lansoprazole | 16 | $203 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wakefield
- Frederick GodleyProvidence$96K
- Mark AndreozziWarwick$15K
- Alejandro VazquezWarwick$10K
- Amit PatelWarwick$7K
- David CameronWesterly$7K
- Jeffrey FeldmanWesterly$4K
- John TarroProvidence$4K
- Barbara GuilletteWarwick$4K
- Eugene StecWesterly$4K
- Faridoon KhanWoonsocket$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.